Ain Shams University: Heart Failure trials

The registry lists 10 Heart Failure studies with Ain Shams University as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 2 3Phase 4 1No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• the Clinical Outcome of Empagliflozin in Pediatric Heart Failure PatientsRecruitingNCT07692256Phase 2
• Delirium and Heart FailureNot yet recruitingNCT07302737
• Effect of Empagliflozin 10 vs 25 mg on LV Remodeling in Diabetic Patients With Anterior STEMI With Reduced LVEFCompletedNCT07169981Phase 2
• Effect of Genetic Polymorphism on the Clinical Outcome to SGLT2 Inhibitors in Heart Failure PatientsActive, not recruitingNCT06901609
• The Impact of Genetic Polymorphism on the Echocardiographic Parameters and Cardiac Fibrosis Markers in Response to Empagliflozin Treatment Among Patients With Heart FailureActive, not recruitingNCT06503601
• Is Sacubitril-valsartan Superior to Dapagliflozin in Improving Myocardial Function PerformanceCompletedNCT06090487Not applicable
• Levosimendan in Patients With Impaired Right Ventricular Function Undergoing Cardiac SurgeryStatus unknownNCT05063370Phase 2
• Early Use of Ivabradine in Heart FailureStatus unknownNCT03701880Not applicable
• Comparison of Lipophilic Versus Hydrophilic Statins on Patients With Heart FailureCompletedNCT03255044Phase 4
• Effect of Genetic Polymorphism on the Clinical Outcome of Patients With Heart FailureCompletedNCT03122834